Skip to content
Disclosery

Vestal Point Capital, LP

Follow

13F filer, CIK 1974915, NEW YORK, NY

Vestal Point Capital, LP reported $3,576,817,318 across 90 holdings for the quarter ended 2026-03-31, in a 13F-HR filed 2026-05-15. Its ten largest share positions make up 40.4% of the portfolio.

Filed (acceptance time not in the bulk data set), ingested 13F-HR 0001974915-26-000004

Period
2026-03-31
Reported value
$3.58B
Holdings
90
Top 10 weight
40.4%
New
37
Sold out
23

Largest buys vs the previous quarter

SecurityShares changeApprox. value
RVMDadded+2,080,000$202M
NBIXnew+1,250,000$165M
RGENadded+842,000$99.2M
ARWRadded+1,375,000$86.2M
DYNadded+3,880,000$70.3M

Ranked by the share change valued at this quarter's implied price (value over shares in the 13F). A position sold out is valued at the previous quarter's price, its last report.

Largest sells vs the previous quarter

SecurityShares changeApprox. value
ACLXexited-2,925,000-$191M
TERNreduced-3,500,000-$185M
TYRAreduced-2,371,000-$90.8M
DXCMexited-1,275,000-$84.6M
MRKexited-775,000-$81.6M

Ranked by the share change valued at this quarter's implied price (value over shares in the 13F). A position sold out is valued at the previous quarter's price, its last report.

Holdings, Q1 2026

Share positions as resolved from 13F-HR 0001974915-26-000004, largest first. % of portfolio is the value over $3,576,817,318, the sum of the share positions whose value is usable for ratios (method).

SecurityHistorySharesValue% of portfolioChangeLatest eventTimeline
RVMDREVOLUTION MEDICINES INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: 1,200,000 shares; 2025Q3: 630,000 shares; 2025Q4: 295,000 shares; 2026Q1: 2,375,000 shares 2,375,000$231M6.46%+2,080,000Timeline
BMRNBIOMARIN PHARMACEUTICAL INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q2: restricted; 2024Q3: 400,000 shares; 2024Q4: 860,000 shares; 2025Q1: not reported; 2025Q2: 500,000 shares; 2025Q3: 830,000 shares; 2025Q4: 3,000,000 shares; 2026Q1: 3,575,000 shares 3,575,000$202M5.65%+575,000Timeline
ABVXABIVAX SAQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: 1,000,000 shares; 2025Q4: 1,900,000 shares; 2026Q1: 1,500,000 shares 1,500,000$167M4.67%-400,000Timeline
NBIXNEUROCRINE BIOSCIENCES INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: 30,000 shares; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: 1,250,000 shares 1,250,000$165M4.6%newTimeline
ARWRARROWHEAD PHARMACEUTICALS INQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: 900,000 shares; 2026Q1: 2,275,000 shares 2,275,000$143M3.99%+1,375,000Timeline
ELVNENLIVEN THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: 250,000 shares; 2025Q3: 1,160,000 shares; 2025Q4: 3,830,000 shares; 2026Q1: 3,250,000 shares 3,250,000$127M3.56%-580,000Timeline
RGENREPLIGEN CORPQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: 400,000 shares; 2025Q4: 83,000 shares; 2026Q1: 925,000 shares 925,000$109M3.05%+842,000Timeline
BCAXBICARA THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q2: restricted; 2024Q3: 425,000 shares; 2024Q4: 710,000 shares; 2025Q1: 2,768,975 shares; 2025Q2: 5,000,000 shares; 2025Q3: 5,100,000 shares; 2025Q4: 3,575,000 shares; 2026Q1: 5,425,000 shares 5,425,000$108M3.02%+1,850,000Timeline
NRIXNURIX THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q2: restricted; 2024Q3: 425,000 shares; 2024Q4: 485,000 shares; 2025Q1: 1,125,552 shares; 2025Q2: 2,000,000 shares; 2025Q3: 3,475,000 shares; 2025Q4: 4,690,000 shares; 2026Q1: 6,500,000 shares 6,500,000$101M2.82%+1,810,000Timeline
APGEAPOGEE THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q2: restricted; 2024Q3: 136,500 shares; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: 425,000 shares; 2025Q4: 550,000 shares; 2026Q1: 1,100,000 shares 1,100,000$92.6M2.59%+550,000Timeline
ASNDASCENDIS PHARMA A/SQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q2: restricted; 2024Q3: 250,000 shares; 2024Q4: 520,000 shares; 2025Q1: 150,142 shares; 2025Q2: 200,000 shares; 2025Q3: 600,000 shares; 2025Q4: 175,000 shares; 2026Q1: 375,000 shares 375,000$85.8M2.4%+200,000Timeline
IMCRIMMUNOCORE HLDGS PLCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: 585,000 shares; 2026Q1: 2,766,868 shares 2,766,868$83.4M2.33%+2,181,868Timeline
TSHATAYSHA GENE THERAPIES INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: 3,000,000 shares; 2025Q3: 5,500,000 shares; 2025Q4: 13,750,000 shares; 2026Q1: 18,000,000 shares 18,000,000$80.5M2.25%+4,250,000Timeline
DYNDYNE THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: 1,800,000 shares; 2025Q2: 727,500 shares; 2025Q3: 2,775,000 shares; 2025Q4: 120,000 shares; 2026Q1: 4,000,000 shares 4,000,000$72.5M2.03%+3,880,000Timeline
SNYSANOFI SAQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q2: restricted; 2024Q3: 150,000 shares; 2024Q4: 750,000 shares; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: 1,400,000 shares 1,400,000$67.5M1.89%newTimeline
BCRXBIOCRYST PHARMACEUTICALS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: 2,250,000 shares; 2026Q1: 7,025,000 shares 7,025,000$66.9M1.87%+4,775,000Timeline
SRRKSCHOLAR ROCK HLDG CORPQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: 1,300,000 shares; 2025Q2: 1,500,000 shares; 2025Q3: 1,500,000 shares; 2025Q4: 700,000 shares; 2026Q1: 1,324,422 shares 1,324,422$65.1M1.82%+624,422Timeline
IMTXIMMATICS N.VQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q2: restricted; 2024Q3: 3,750,000 shares; 2024Q4: 6,275,000 shares; 2025Q1: 7,192,700 shares; 2025Q2: 6,250,000 shares; 2025Q3: 6,350,000 shares; 2025Q4: 6,125,000 shares; 2026Q1: 6,175,000 shares 6,175,000$60.8M1.7%+50,000Timeline
BMYBRISTOL-MYERS SQUIBB COQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q2: restricted; 2024Q3: 250,000 shares; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: 250,000 shares; 2026Q1: 1,000,000 shares 1,000,000$60.6M1.7%+750,000Timeline
ALCALCON AGQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: 525,000 shares; 2025Q3: 1,100,000 shares; 2025Q4: 1,105,000 shares; 2026Q1: 800,000 shares 800,000$60.3M1.69%-305,000Timeline
GLUEMONTE ROSA THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q2: restricted; 2024Q3: 930,000 shares; 2024Q4: 425,000 shares; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: 800,000 shares; 2025Q4: 775,000 shares; 2026Q1: 3,603,465 shares 3,603,465$59.3M1.66%+2,828,465Timeline
VERAVERA THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: 1,075,000 shares; 2025Q1: 2,500,000 shares; 2025Q2: 3,100,000 shares; 2025Q3: 760,000 shares; 2025Q4: 550,000 shares; 2026Q1: 1,368,159 shares 1,368,159$55M1.54%+818,159Timeline
TERNTERNS PHARMACEUTICALS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: 4,500,000 shares; 2026Q1: 1,000,000 shares 1,000,000$52.7M1.47%-3,500,000Timeline
GMEDGLOBUS MED INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: 325,000 shares; 2025Q1: 200,000 shares; 2025Q2: 500,000 shares; 2025Q3: 1,250,000 shares; 2025Q4: 1,275,000 shares; 2026Q1: 610,520 shares 610,520$52.6M1.47%-664,480Timeline
BSXBOSTON SCIENTIFIC CORPQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: 800,000 shares 800,000$50.2M1.4%newTimeline
NUVLNUVALENT INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: 600,000 shares; 2025Q1: 1,075,000 shares; 2025Q2: 1,075,000 shares; 2025Q3: 1,100,000 shares; 2025Q4: 46,000 shares; 2026Q1: 481,715 shares 481,715$49.4M1.38%+435,715Timeline
COGTCOGENT BIOSCIENCES INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: 3,000,000 shares; 2025Q2: 3,080,000 shares; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: 1,230,888 shares 1,230,888$47.4M1.32%newTimeline
ANROALTO NEUROSCIENCE INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q2: restricted; 2024Q3: 650,000 shares; 2024Q4: 915,000 shares; 2025Q1: 915,000 shares; 2025Q2: 950,000 shares; 2025Q3: 950,000 shares; 2025Q4: 2,485,000 shares; 2026Q1: 2,064,075 shares 2,064,075$46.4M1.3%-420,925Timeline
RAPPRAPPORT THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: 950,000 shares; 2025Q4: 1,110,000 shares; 2026Q1: 1,436,229 shares 1,436,229$44.9M1.26%+326,229Timeline
IRONDISC MEDICINE INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: 140,000 shares; 2025Q3: 500,000 shares; 2025Q4: 735,000 shares; 2026Q1: 700,000 shares 700,000$44.8M1.25%-35,000Timeline
UTHRUNITED THERAPEUTICS CORP DELQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: 75,000 shares 75,000$44.5M1.24%newTimeline
CLDXCELLDEX THERAPEUTICS INC NEWQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: 305,000 shares; 2025Q1: 198,646 shares; 2025Q2: 1,750,000 shares; 2025Q3: 1,205,000 shares; 2025Q4: 1,165,000 shares; 2026Q1: 1,224,165 shares 1,224,165$38.8M1.09%+59,165Timeline
KALVKALVISTA PHARMACEUTICALS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q2: restricted; 2024Q3: 4,000,000 shares; 2024Q4: 4,770,000 shares; 2025Q1: 4,751,292 shares; 2025Q2: 4,675,000 shares; 2025Q3: 750,000 shares; 2025Q4: 1,890,000 shares; 2026Q1: 1,850,000 shares 1,850,000$37.2M1.04%-40,000Timeline
XENEXENON PHARMACEUTICALS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q2: restricted; 2024Q3: 825,000 shares; 2024Q4: 810,000 shares; 2025Q1: 1,300,000 shares; 2025Q2: 2,000,000 shares; 2025Q3: 1,100,000 shares; 2025Q4: 600,000 shares; 2026Q1: 639,900 shares 639,900$37.2M1.04%+39,900Timeline
SLDBSOLID BIOSCIENCES INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q2: restricted; 2024Q3: 2,800,000 shares; 2024Q4: 2,850,000 shares; 2025Q1: 1,753,558 shares; 2025Q2: 1,505,000 shares; 2025Q3: 2,975,000 shares; 2025Q4: 5,815,000 shares; 2026Q1: 5,000,000 shares 5,000,000$36M1.01%-815,000Timeline
DRUGBRIGHT MINDS BIOSCIENCES INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: 492,319 shares 492,319$35.9M1%newTimeline
PTGXPROTAGONIST THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: 326,159 shares 326,159$34.4M0.96%newTimeline
DNLIDENALI THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: 465,000 shares; 2026Q1: 1,773,326 shares 1,773,326$34M0.95%+1,308,326Timeline
REGNREGENERON PHARMACEUTICALSQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: 20,000 shares; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: 25,000 shares; 2025Q4: not reported; 2026Q1: 40,000 shares 40,000$30.9M0.86%newTimeline
WATWATERS CORPQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: 100,000 shares 100,000$29.8M0.83%newTimeline
VKTXVIKING THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: 914,147 shares 914,147$29.7M0.83%newTimeline
INSPINSPIRE MED SYS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: 135,000 shares; 2025Q4: not reported; 2026Q1: 539,269 shares 539,269$27.8M0.78%newTimeline
CBIOCRESCENT BIOPHARMA INC.Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: 1,500,000 shares; 2026Q1: 1,500,000 shares 1,500,000$27.6M0.77%0Timeline
TRVITREVI THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: 2,166,504 shares 2,166,504$25.8M0.72%newTimeline
LXEOLEXEO THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q2: restricted; 2024Q3: 850,000 shares; 2024Q4: 1,200,000 shares; 2025Q1: 1,136,249 shares; 2025Q2: 3,228,161 shares; 2025Q3: 3,250,000 shares; 2025Q4: 4,475,000 shares; 2026Q1: 4,475,000 shares 4,475,000$25.7M0.72%0Timeline
SLNOSOLENO THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q2: restricted; 2024Q3: 720,000 shares; 2024Q4: 1,060,000 shares; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: 730,000 shares 730,000$24.4M0.68%newTimeline
BBNXBETA BIONICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: 550,000 shares; 2025Q3: 600,000 shares; 2025Q4: 600,000 shares; 2026Q1: 2,211,518 shares 2,211,518$22.2M0.62%+1,611,518Timeline
NKTRNEKTAR THERAPEUTICSQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: 285,000 shares 285,000$20.5M0.57%newTimeline
CYTKCYTOKINETICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q2: restricted; 2024Q3: 1,500,000 shares; 2024Q4: 2,350,000 shares; 2025Q1: 2,590,531 shares; 2025Q2: 2,975,000 shares; 2025Q3: 725,000 shares; 2025Q4: not reported; 2026Q1: 300,000 shares 300,000$19.8M0.55%newTimeline
AZNASTRAZENECA PLCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: 100,000 shares 100,000$19.7M0.55%newTimeline
WSTWEST PHARMACEUTICAL SVSC INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: 75,000 shares 75,000$18.8M0.53%newTimeline
GEHCGE HEALTHCARE TECHNOLOGIES IQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: 204,130 shares; 2025Q2: 700,000 shares; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: 250,000 shares 250,000$17.8M0.5%newTimeline
SGPSPYGLASS PHARMA INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: 666,760 shares 666,760$17.3M0.48%newTimeline
ZBHZIMMER BIOMET HOLDINGS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: 50,000 shares; 2025Q3: not reported; 2025Q4: 150,000 shares; 2026Q1: 190,000 shares 190,000$17.2M0.48%+40,000Timeline
MDGLMADRIGAL PHARMACEUTICALS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q2: restricted; 2024Q3: 30,000 shares; 2024Q4: 95,000 shares; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: 31,468 shares 31,468$16.5M0.46%newTimeline
WGSGENEDX HOLDINGS CORPQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: 250,000 shares 250,000$16.1M0.45%newTimeline
DMRADAMORA THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: 600,000 shares 600,000$15.5M0.43%newTimeline
AGIOAGIOS PHARMACEUTICALS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q2: restricted; 2024Q3: 760,000 shares; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: 127,000 shares; 2025Q4: 325,000 shares; 2026Q1: 450,000 shares 450,000$15.2M0.43%+125,000Timeline
ENGNENGENE HOLDINGS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: 370,000 shares; 2025Q1: 370,000 shares; 2025Q2: 370,000 shares; 2025Q3: 370,000 shares; 2025Q4: 1,055,000 shares; 2026Q1: 2,165,000 shares 2,165,000$14.7M0.41%+1,110,000Timeline
SVRASAVARA INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q2: restricted; 2024Q3: 8,090,000 shares; 2024Q4: 10,775,000 shares; 2025Q1: 11,000,000 shares; 2025Q2: 11,015,000 shares; 2025Q3: 4,015,000 shares; 2025Q4: 1,606,000 shares; 2026Q1: 2,600,052 shares 2,600,052$14.2M0.4%+994,052Timeline
TARSTARSUS PHARMACEUTICALS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q2: restricted; 2024Q3: 230,000 shares; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: 200,000 shares 200,000$14M0.39%newTimeline
VYGRVOYAGER THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q2: restricted; 2024Q3: 490,000 shares; 2024Q4: 1,230,000 shares; 2025Q1: 1,249,418 shares; 2025Q2: 1,475,000 shares; 2025Q3: 1,475,000 shares; 2025Q4: 1,475,000 shares; 2026Q1: 3,002,936 shares 3,002,936$11.6M0.32%+1,527,936Timeline
PODDINSULET CORPQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: 50,601 shares 50,601$10.6M0.3%newTimeline
TECXTECTONIC THERAPEUTIC INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: 328,000 shares; 2026Q1: 328,000 shares 328,000$10.1M0.28%0Timeline
SRZNSURROZEN INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: 338,611 shares 338,611$9.86M0.28%newTimeline
ARVNARVINAS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: 905,465 shares 905,465$9.6M0.27%newTimeline
MPLTMAPLIGHT THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: 385,000 shares; 2026Q1: 420,000 shares 420,000$8.54M0.24%+35,000Timeline
FULCFULCRUM THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: 950,000 shares; 2026Q1: 1,100,000 shares 1,100,000$8.44M0.24%+150,000Timeline
OKURONKURE THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: 635,000 shares; 2025Q1: 635,000 shares; 2025Q2: 635,000 shares; 2025Q3: 635,000 shares; 2025Q4: 635,000 shares; 2026Q1: 1,839,819 shares 1,839,819$7.62M0.21%+1,204,819Timeline
MYGNMYRIAD GENETICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: 600,000 shares; 2025Q4: 1,223,000 shares; 2026Q1: 1,648,000 shares 1,648,000$7.42M0.21%+425,000Timeline
OLMAOLEMA PHARMACEUTICALS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: 1,650,000 shares; 2026Q1: 428,551 shares 428,551$6.39M0.18%-1,221,449Timeline
AVRANTERIS TECHNOLOGIES GLOBALQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: 1,144,780 shares 1,144,780$6.35M0.18%newTimeline
QUREUNIQURE NVQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q2: restricted; 2024Q3: 4,750,000 shares; 2024Q4: 3,025,000 shares; 2025Q1: 4,792,572 shares; 2025Q2: 3,700,000 shares; 2025Q3: 225,000 shares; 2025Q4: not reported; 2026Q1: 358,996 shares 358,996$5.87M0.16%newTimeline
CADLCANDEL THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: 1,125,000 shares 1,125,000$5.51M0.15%newTimeline
PALIPALISADE BIO INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: 2,500,000 shares 2,500,000$4.38M0.12%newTimeline
VCYTVERACYTE INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: 130,687 shares 130,687$4.21M0.12%newTimeline
ZBIOZENAS BIOPHARMA INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: 200,000 shares 200,000$3.91M0.11%newTimeline
GERNGERON CORPQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q2: restricted; 2024Q3: 1,050,000 shares; 2024Q4: 11,000,000 shares; 2025Q1: 22,005,340 shares; 2025Q2: 23,775,000 shares; 2025Q3: 17,225,000 shares; 2025Q4: 11,320,000 shares; 2026Q1: 2,540,000 shares 2,540,000$3.78M0.11%-8,780,000Timeline
MNPRMONOPAR THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: 65,418 shares 65,418$3.58M0.1%newTimeline
ZURAZURA BIO LTDQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: 511,000 shares 511,000$3.04M0.09%newTimeline
NVCRNOVOCURE LTDQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: 400,000 shares; 2025Q4: 525,000 shares; 2026Q1: 250,000 shares 250,000$2.73M0.08%-275,000Timeline
NYXHNYXOAH S AQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: 2,924,216 shares; 2025Q1: 2,318,954 shares; 2025Q2: 1,402,002 shares; 2025Q3: 1,107,413 shares; 2025Q4: 1,107,000 shares; 2026Q1: 868,661 shares 868,661$2.54M0.07%-238,339Timeline
URGNUROGEN PHARMA LTDQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q2: restricted; 2024Q3: 400,000 shares; 2024Q4: 1,630,000 shares; 2025Q1: 2,152,957 shares; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: 139,079 shares 139,079$2.5M0.07%newTimeline
PASGPASSAGE BIO INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: 305,000 shares; 2025Q4: 305,000 shares; 2026Q1: 305,000 shares 305,000$2.39M0.07%0Timeline
TYRATYRA BIOSCIENCES INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: 990,000 shares; 2025Q1: 2,879,829 shares; 2025Q2: 2,655,000 shares; 2025Q3: 2,425,000 shares; 2025Q4: 2,425,000 shares; 2026Q1: 54,000 shares 54,000$2.07M0.06%-2,371,000Timeline
RGNXREGENXBIO INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: 34,000 shares; 2026Q1: 108,525 shares 108,525$909K0.03%+74,525Timeline
TENXTENAX THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q2: restricted; 2024Q3: 83,333 shares; 2024Q4: 55,189 shares; 2025Q1: 53,439 shares; 2025Q2: 53,439 shares; 2025Q3: 53,439 shares; 2025Q4: 53,439 shares; 2026Q1: 53,439 shares 53,439$854K0.02%0Timeline
MGNXMACROGENICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q2: restricted; 2024Q3: 830,000 shares; 2024Q4: 280,000 shares; 2025Q1: 280,000 shares; 2025Q2: 280,000 shares; 2025Q3: 280,000 shares; 2025Q4: 280,000 shares; 2026Q1: 280,000 shares 280,000$809K0.02%0Timeline
ABSIABSCI CORPORATIONQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: 232,219 shares 232,219$697K0.02%newTimeline
APREAPREA THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: 350,000 shares 350,000$267K0.01%newTimeline

Sold out in Q1 2026

Positions in the previous quarter's report that this quarter's report no longer lists.

SecurityShares beforeValue beforeType
QQQINVESCO QQQ TR350,000$215Mput
ACLXARCELLX INC2,925,000$191Mshares
DXCMDEXCOM INC1,275,000$84.6Mshares
MRKMERCK & CO INC775,000$81.6Mshares
ABTABBOTT LABORATORIES600,000$75.2Mshares
JAZZJAZZ PHARMACEUTICALS PLC290,000$49.3Mshares
DAWNDAY ONE BIOPHARMACEUTICALS I5,200,000$48.5Mshares
AXSMAXSOME THERAPEUTICS INC.210,000$38.4Mshares
LNTHLANTHEUS HLDGS INC360,000$24Mshares
ZYMEZYMEWORKS INC865,000$22.8Mshares
UPBUPSTREAM BIO INC720,000$19.5Mshares
PENPENUMBRA INC50,000$15.5Mshares
MIND MEDICINE MINDMED INCMIND MEDICINE MINDMED INC637,000$8.53Mshares
GILDGILEAD SCIENCES INC50,000$6.14Mshares
DBVTDBV TECHNOLOGIES S A300,000$5.75Mshares
MIRMMIRUM PHARMACEUTICALS INC66,000$5.21Mshares
LENZLENZ THERAPEUTICS INC275,000$4.4Mshares
RZLTREZOLUTE INC1,686,000$3.98Mshares
STROSUTRO BIOPHARMA INC243,000$2.81Mshares
GPCRSTRUCTURE THERAPEUTICS INC35,000$2.43Mshares
BDTXBLACK DIAMOND THERAPEUTICS I870,000$2.11Mshares
FATEFATE THERAPEUTICS INC1,725,000$1.69Mshares
ALECALECTOR INC755,000$1.18Mshares

How Q1 2026 was built

Available 13F filings of this filer for the quarter and their roles: the base report is the latest original or restatement, NEW HOLDINGS amendments filed after it are added (method).

FilingRoleAmendmentFiledAcceptedIngested
13F-HR 0001974915-26-000004 base2026-05-15acceptance time not in the bulk data set